Ionis Pharmaceuticals: Harnessing RNA-Targeted Therapies For Long-Term Shareholder Value

kemalbas Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is a biopharmaceutical company specializing in RNA-targeted therapies. It uses antisense DNA technology to design drugs that regulate the production of specific proteins to treat neurological and cardiometabolic diseases, directly addressing their root causes. The company presents an extensive pipeline with partnered and in-house drug developments to address several conditions. It also collaborates with major pharmaceutical companies like Biogen (BIIB), Ast ...